IDEAYA BIOSCIENCES INC
IDYA · NASDAQ
Updated at 2026-10-14 08:31:37
- Today's High
- $36.20
- Today’s Low
- $34.25
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $35.98
- Previous Close
- $36.06
- Volume
- 441.47K
- Market Cap
- $3.47B
- P/E Ratio
- --
- EPS
- $-1.94
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 5000 SHORELINE COURT, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2019-05-23
- Fiscal Year End
- December
- Shares Outstanding
- 95.08M
- CIK
- 0001676725
- Website
- www.ideayabio.com
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$8.85M
2026-03-31
$6.56M
2025-12-31
$10.87M
2025-09-30
$207.83M
Operating Expenses
2026-06-30
$131.14M
2026-03-31
$115.1M
2025-12-31
$105.44M
2025-09-30
$99.38M
Net Income
2026-06-30
-$112.45M
2026-03-31
-$98.53M
2025-12-31
-$83.27M
2025-09-30
$119.24M
Net Profit Margin
2026-06-30
-1.26K%
2026-03-31
-1.5K%
2025-12-31
-765.65%
2025-09-30
57.37%
Earnings Per Share
2026-06-30
$-1.22
2026-03-31
$-1.11
2025-12-31
$-0.94
2025-09-30
$1.33
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$121.17M
2026-03-31
-$97.85M
2025-12-31
-$82.55M
2025-09-30
$119.9M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $8.85M | $6.56M | $10.87M | $207.83M |
| Operating Expenses | $131.14M | $115.1M | $105.44M | $99.38M |
| Net Income | -$112.45M | -$98.53M | -$83.27M | $119.24M |
| Net Profit Margin | -1.26K% | -1.5K% | -765.65% | 57.37% |
| Earnings Per Share | $-1.22 | $-1.11 | $-0.94 | $1.33 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$121.17M | -$97.85M | -$82.55M | $119.9M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.